Cargando…
How Far Could We Go with Open Data – A Case Study for TRPV1 Antagonists
Publicly open databases of small compounds have become an indispensable tool for chemoinformaticians for collection and preparation of datasets suitable for drug discovery questions. Since these databases comprise compounds coming from structure-activity relationship (SAR) studies performed by diffe...
Autores principales: | Tsareva, Daria A, Ecker, Gerhard F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743172/ https://www.ncbi.nlm.nih.gov/pubmed/23956804 http://dx.doi.org/10.1002/minf.201300019 |
Ejemplares similares
-
Working alliance with an avatar: How far can we go with internet interventions?
por: Heim, Eva, et al.
Publicado: (2018) -
How far can we go in precision with ALR?
por: Blondel, A
Publicado: (1990) -
Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go
por: Gajjela, Harini, et al.
Publicado: (2021) -
Paediatric Surgery on the African Continent: How Far Have We Come; How Far Can We Go?
por: Numanoglu, Alp
Publicado: (2023) -
Undergraduate medical education; how far should we go?
por: Benamer, Hani TS
Publicado: (2007)